Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3630 (117th)

Lymphedema Treatment Act

referredUnited States· United States Congress· EN

Introduced

28 May 2021

Last action

17 November 2022 · Floor

Status

Received in the Senate and Read twice and referred to the Committee on Finance.

Sponsors

Rep. Schakowsky, Janice D. [D-IL-9], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Blumenauer, Earl [D-OR-3], Rep. Kelly, Mike [R-PA-16], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Sewell, Terri A. [D-AL-7], Rep. DeGette, Diana [D-CO-1], Rep. Levin, Andy [D-MI-9], Rep. Aderholt, Robert B. [R-AL-4], Rep. Axne, Cynthia [D-IA-3], Rep. Ferguson, A. Drew, IV [R-GA-3], Rep. Wilson, Joe [R-SC-2], Rep. Joyce, John [R-PA-13], Rep. Brown, Anthony G. [D-MD-4], Marie Newman, Rep. Smith, Adam [D-WA-9], Sen. Mullin, Markwayne [R-OK], Rep. Wild, Susan [D-PA-7], Rep. Ross, Deborah K. [D-NC-2], Rep. Wasserman Schultz, Debbie [D-FL-25], Rep. Boyle, Brendan F. [D-PA-2], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Titus, Dina [D-NV-1], Rep. Lawrence, Brenda L. [D-MI-14], Rep. Velázquez, Nydia M. [D-NY-7], Rep. McCollum, Betty [D-MN-4], Rep. O'Halleran, Tom [D-AZ-1], Rep. Suozzi, Thomas R. [D-NY-3], Rep. Doyle, Michael F. [D-PA-14], Rep. Price, David E. [D-NC-4], Rep. Meeks, Gregory W. [D-NY-5], Rep. Butterfield, G. K. [D-NC-1], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Herrera Beutler, Jaime [R-WA-3], Rep. Doggett, Lloyd [D-TX-37], Rep. Castro, Joaquin [D-TX-20], Rep. Larson, John B. [D-CT-1], Rep. Garcia, Sylvia R. [D-TX-29], Rep. Scanlon, Mary Gay [D-PA-5], Rep. Johnson, Bill [R-OH-6], Rep. McNerney, Jerry [D-CA-9], Rep. Wittman, Robert J. [R-VA-1], Rep. Scott, Austin [R-GA-8], Rep. Tonko, Paul [D-NY-20], Rep. Cicilline, David N. [D-RI-1], Rep. Matsui, Doris O. [D-CA-7], Rep. Connolly, Gerald E. [D-VA-11], Rescom. González-Colón, Jenniffer [R-PR-At Large]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Summary

Lymphedema Treatment Act This bill provides for Medicare coverage of lymphedema compression treatment items. Specifically, the bill provides for coverage of (1) standard and custom fitted gradient compression garments that are prescribed by a physician or other specified health care professional to treat lymphedema, and (2) other devices determined to be effective in the prevention or treatment of lymphedema.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 28 May 2021

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 28 May 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 28 May 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 31 May 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 8 June 2022

    Calendars

    Motion to place bill on Consensus Calendar filed by Ms. Schakowsky.

    Source: Calendars

  6. 12 July 2022

    Committee

    Subcommittee on Health Discharged.

    Source: Committee

  7. 13 July 2022

    Reported

    Ordered to be Reported (Amended) by Voice Vote.

    Source: Committee

  8. 13 July 2022

    Committee

    Committee Consideration and Mark-up Session Held.

    Source: Committee

  9. 22 July 2022

    Calendars

    Placed on the Union Calendar, Calendar No. 336.

    Source: Calendars

  10. 22 July 2022

    Discharge

    Committee on Ways and Means discharged.

    Source: Discharge

  11. 22 July 2022

    Committee

    Committee on Ways and Means discharged.

    Source: Committee

  12. 22 July 2022

    Reported

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-430, Part I.

    Source: Committee

  13. 22 July 2022

    Reported

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-430, Part I.

    Source: Committee

  14. 14 November 2022

    Vote

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

    Source: Floor

  15. 14 November 2022

    Floor

    DEBATE - The House proceeded with forty minutes of debate on H.R. 3630.

    Source: Floor

  16. 14 November 2022

    Floor

    Considered under suspension of the rules. (consideration: CR H8469-8471)

    Source: Floor

  17. 14 November 2022

    Floor

    Mr. Pallone moved to suspend the rules and pass the bill, as amended.

    Source: Floor

  18. 17 November 2022

    Introduced

    Received in the Senate and Read twice and referred to the Committee on Finance.

    Source: IntroReferral

  19. 17 November 2022

    Passed

    Motion to reconsider laid on the table Agreed to without objection.

    Source: Floor

  20. 17 November 2022

    Vote

    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 13 (Roll no. 485). (text: 11/14/2022 CR H8469)

    Source: Floor

  21. 17 November 2022

    Vote

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 13 (Roll no. 485).

    Source: Floor

  22. 17 November 2022

    Floor

    Considered as unfinished business. (consideration: CR H8576-8577)

    Source: Floor

Votes

17 November 2022 · passed · On Motion to Suspend the Rules and Pass, as Amended · Passed · Official source

Yes 402 · No 13 · Abstain — · Absent/not voting 17

Showing the first 4 recorded positions. Vote totals above are complete.

Versions

Documents

11 official files

Referred in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Referred in Senate (text)

    Referred in Senate · EN · 17 November 2022

    ViewDownloadOpen at official source

  • Referred in Senate (PDF)

    Referred in Senate · EN · 17 November 2022

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Engrossed in House (text)

    Engrossed in House · EN · 17 November 2022

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Engrossed in House (PDF)

    Engrossed in House · EN · 17 November 2022

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Passed House

    summary · EN · 17 November 2022

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Reported in House (text)

    Reported in House · EN · 22 July 2022

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Reported in House (PDF)

    Reported in House · EN · 22 July 2022

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Reported to House, Part I

    summary · EN · 22 July 2022

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 28 May 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (PDF)

    Introduced in House · EN · 28 May 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 28 May 2021

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 361 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.